HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shares shot up 0.6% on Wednesday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The firm has a fifty day simple moving average of $25.31 and a 200-day simple moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
See Also
- Five stocks we like better than HemaCare
- What Are Some of the Best Large-Cap Stocks to Buy?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- High Flyers: 3 Natural Gas Stocks for March 2022
- How Do Stock Buybacks Affect Shareholders?
- How to Invest in Small Cap Stocks
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
